[CLSTR]
< Back to situation

[REVISION HISTORY]

Coffee intake linked to lower disease risk

Updated 4 times since CLSTR started tracking revisions of this situation.

What changed

2026-07-27 19:11 UTC → 2026-07-28 17:38 UTC · added removed

Coffee intake linked to liver and heart health lower disease risk

Research through mid‑2026 continues to associate show that regular coffee and tea consumption is associated with lower rates of liver disease, liver‑related cancer, cardiovascular events and overall mortality. Large cohort Cohort analyses in the United Kingdom, United States and Japan show demonstrate a clear dose‑response: 1–2 cups daily reduce cirrhosis risk by ~20 about 20 % and liver‑related death by 31 %; five or more cups lower cirrhosis by 32 %, hepatocellular carcinoma by up to 47 % and liver mortality by roughly 42 %. A July 2026 UK Biobank analysis of 354,957 participants over a median 13 years 13‑year follow‑up confirmed these findings, reporting a 47 % reduction in hepatocellular carcinoma and similar benefits for decaffeinated coffee. Imaging of a subset indicated coffee, with imaging showing lower liver fat, iron and fibro‑inflammation among heavy consumers, though the study remains observational and cannot prove causality. The Cedars‑Sinai study of 355,000 U.S. adults reinforced a one‑third lower chance of liver fibrosis and nearly a 50 % cut in liver cancer risk for five‑plus cups daily. heavier drinkers. The American Heart Association’s 2026 statement affirmed Association (AHA) reiterated that up to 400 mg of caffeine per day (≈3–5 — roughly three to five eight‑ounce cups) cups of black coffee — is safe for most healthy adults and linked moderate intake to lower incidences of heart failure, coronary disease, stroke stroke, heart failure and type‑2 diabetes, with no increase in without increasing atrial fibrillation risk. Benefits apply when coffee is consumed plain. Additional clarification highlights that excessive intake plain; added sugars, flavored syrups or heavy cream can cause anxiety, insomnia, gastrointestinal upset and palpitations; mental‑health authorities advise limits for vulnerable individuals. Conversely, moderate consumption (2–5 cups) is associated with a 10 % lower heart‑attack risk, 20 % lower stroke risk and 30 % lower type‑2 diabetes risk, benefits attributed to coffee’s polyphenols negate protective effects, and antioxidants. Filtered coffee is recommended, as unfiltered brews may raise LDL cholesterol. Meta‑analyses later in 2026 linked three to New meta‑analyses broaden the cancer picture. A review of 14 international studies found that more than four cups daily to increased longevity cut the risk of head‑and‑neck cancer by about 17 % and better cognition lowered oral‑cavity and pharynx tumors by 20‑30 %; decaffeinated coffee showed a possible protective effect against liver and some mouth cancers. Additional reviews reported modest reductions in older adults, especially women. breast‑cancer risk among post‑menopausal women and a 20 % lower risk of malignant melanoma for those drinking four or more cups per day, with each extra cup reducing melanoma risk by roughly 4.5 %.

Versions

  1. 2026-07-28 17:38 UTC Coffee intake linked to lower disease risk
  2. 2026-07-27 19:11 UTC Coffee intake linked to liver and heart health
  3. 2026-07-27 12:15 UTC Coffee intake linked to liver and heart health
  4. 2026-07-27 01:02 UTC Coffee intake linked to liver and heart health
  5. 2026-07-26 15:35 UTC Coffee intake linked to liver and heart health

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.